Literature DB >> 32860280

COVID-19 in a state of Brazilian Northeast: Prevalence and associated factors in people with flu-like syndrome.

Thiago S Garces1, George J B Sousa1, Raquel S Florêncio1, Virna R F Cestari1, Maria L D Pereira1, Thereza M M Moreira1.   

Abstract

AIMS AND
OBJECTIVES: To estimate the prevalence and associated factors of COVID-19 in people with flu-like syndrome in Ceará, Brazil.
BACKGROUND: COVID-19 is an infectious disease that has led to a worldwide public health emergency. More than 30,000 cases were confirmed in Brazil, especially in the States of São Paulo, Rio de Janeiro and Ceará. The capital of the Ceará State is the one with the highest incidence of COVID-19 in Brazil. Estimating the prevalence of the disease and its associated factors is important to offer adequate health care.
DESIGN: A cross-sectional study with secondary data of people notified with flu-like syndrome and COVID-19 test results.
METHODS: 19,967 cases of flu-like syndrome were analysed according to the result of the COVID-19 test. Predictive variables were as follows: age range, sex, women in puerperium, presence or absence of cardiovascular diseases, diabetes, haematological illness, immunodeficiencies, neurological diseases, obesity, renal diseases and Down syndrome. Robust Poisson regression models estimated the prevalence ratios of COVID-19. The research was reported via STROBE guidelines for cross-sectional studies.
RESULTS: The prevalence of COVID-19 in the population was 10.37%. In the final model, the following variables were associated with COVID-19: aged people, male sex, cardiovascular diseases and diabetes.
CONCLUSION: Among the flu-like syndrome cases, COVID-19 prevalence was high. In the Ceará State, clinical factors such as aged people, male sex, cardiovascular diseases and diabetes can enhance the prevalence of COVID-19 by up to 2.57 times. RELEVANCE TO CLINICAL PRACTICE: The identification of factors that are associated with the enhanced prevalence of COVID-19 facilitates early diagnosis, and adequate and prompt treatment. This knowledge may avoid an unfavourable prognosis of the disease.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  COVID-19; Epidemiology; Prevalence

Mesh:

Year:  2020        PMID: 32860280     DOI: 10.1111/jocn.15472

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  1 in total

1.  Prevalence of anti-SARS-CoV-2 antibodies in outpatients of a large public university hospital in Sao Paulo, Brazil.

Authors:  Luanda Mara da Silva Oliveira; Bruna Tiaki Tiyo; Lais Teodoro da Silva; Luiz Augusto Marcondes Fonseca; Rosana Coura Rocha; Vera Aparecida Dos Santos; Carina Ceneviva; Anderson Aparecido Bedin; Alexandre de Almeida; Alberto José da Silva Duarte; Telma Miyuki Oshiro
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2020-11-13       Impact factor: 1.846

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.